Drug intelligence / Profile preview

fibrin gel

Development stage
Phase 3
Lead developer
Takeda
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration
Topical, Surgical Implantation, Ophthalmic, Intraarticular, Injectable
01

Overview

Fibrin gel is a biodegradable, biocompatible biomaterial formed by the polymerization of fibrinogen and thrombin—key proteins in the blood clotting cascade. Upon mixing these components (often with calcium), thrombin cleaves fibrinogen to produce insoluble fibrin monomers that spontaneously assemble into a three-dimensional network or gel. This structure mimics natural blood clots and serves as a scaffold for cell attachment, migration, and proliferation during tissue repair. Fibrin gels are widely used clinically as hemostatic agents (fibrin glue/sealant) to control bleeding during surgery when conventional methods are insufficient or impractical. They also serve as scaffolds in tissue engineering for wound healing, cartilage repair, cardiovascular applications, ophthalmic procedures (e.g., corneal transplantation), nerve reattachment, skin graft adhesion, and regenerative medicine research. Fibrin gels degrade naturally via plasmin-mediated fibrinolysis and exhibit minimal inflammation or foreign body reaction[1][2][6][9].

Other names
fibrin gluefibrin sealantfibrin hydrogel
02

Targets

Fibrin knob-hole interaction sitesCOL1 (Collagen type I)Factor XIIIa crosslinking sites on fibrinFGB (Fibrinogen beta chain)F2 (Thrombin)

Beyond the preview

Go deeper on fibrin gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fibrin gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call